Physician profile
Jason A Smith
NPI 1780818047
$19,166.89
in general payments reported to CMS, 2019-2025
35 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 92% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,856 · 2020: $1,802 · 2021: $478 · 2022: $1,202 · 2023: $1,198 · 2024: $2,953 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,746 · Travel and Lodging: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,746.40 |
| Travel and Lodging | $1,082.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $9,431.32 | 2019-2021 | |
| Medtronic USA, INC. | $1,564.23 | 2019-2020 | |
| Nevro Corp. | $1,382.34 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $1,197.79 | 2023-2024 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $877.29 | 2019-2025 | General - Pain Management, Watchman Flx, Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $870.61 | 2025 | Senza |
| Bioventus LLC | $774.33 | 2022-2024 | Stimrouter Implantable Kit, Durolane, L360 Thigh System |
| Medtronic, INC. | $638.44 | 2022-2025 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Infinity Occipitocervical Upper Thoracic System, Intellis Adaptivestim |
| Abbott Laboratories | $542.94 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $434.26 | 2023-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $137.72 | 2025 | Prospera |
| Ferring Pharmaceuticals INC. | $137.42 | 2019-2023 | Euflexxa |
| Stryker Corporation | $136.22 | 2025 | Mild Device Kit, Optablate |
| Ipsen Biopharmaceuticals, INC | $131.42 | 2019-2024 | Dysport |
| Mml US, INC. | $119.10 | 2025 | Reactiv8 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $112.87 | 2022-2024 | Botox |
| Pfizer INC. | $64.44 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.17 | 2019-2022 | |
| Depuy Synthes Sales INC. | $55.50 | 2025 | Orthovisc, Monovisc |
| Averitas Pharma INC. | $53.55 | 2023-2024 | Qutenza |
| Ibsa Pharma INC. | $52.85 | 2023-2025 | Tirosint, Licart, Flector |
| Allergan, INC. | $52.78 | 2019-2021 | |
| Davol INC. | $50.58 | 2025 | Channel Drain |
| Spr Therapeutics, INC | $41.84 | 2019-2024 | Sprint Pns System |
| Nuvasive, INC. | $39.05 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $29.38 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $29.37 | 2022-2023 | Seglentis |
| Redhill Biopharma INC. | $28.56 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $28.00 | 2019 | |
| Novo Nordisk INC | $27.59 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.93 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.89 | 2021 | |
| Pacira Therapeutics, INC. | $14.00 | 2019 | |
| Daiichi Sankyo INC. | $13.67 | 2019 | |
| Merck Sharp & Dohme LLC | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.